Suppr超能文献

行心脏手术的患者血清氯峰值和高氯血症不能单纯用富含氯的静脉输液来解释:LICRA 试验的事后分析。

Peak Serum Chloride and Hyperchloremia in Patients Undergoing Cardiac Surgery Is Not Explained by Chloride-Rich Intravenous Fluid Alone: A Post-Hoc Analysis of the LICRA Trial.

机构信息

Alfred Hospital, Monash University, Melbourne, Victoria, Australia; Vanderbilt University Medical Center, Nashville, TN.

Alfred Hospital, Monash University, Melbourne, Victoria, Australia.

出版信息

J Cardiothorac Vasc Anesth. 2021 May;35(5):1321-1331. doi: 10.1053/j.jvca.2020.07.085. Epub 2020 Aug 7.

Abstract

OBJECTIVES

With the exception of 0.9% saline, little is known about factors that may contribute to increased serum chloride concentration (S) in patients undergoing cardiac surgery. For the present study, the authors sought to characterize the association between administered chloride load from intravenous fluid and other perioperative variables, with peak perioperative S.

DESIGN

Secondary analysis of data from a previously published controlled clinical trial in which patients were assigned to a chloride-rich or chloride-limited perioperative fluid strategy (NCT02020538).

SETTING

Academic medical center.

PARTICIPANTS

The study comprised 1,056 adult patients with normal preoperative S undergoing cardiac surgery.

INTERVENTIONS

None MEASUREMENTS AND MAIN RESULTS: Peak perioperative S and hyperchloremia, defined as peak S >110 mmol/L, were selected as co-primary endpoints. Regression modeling identified factors independently associated with these endpoints. Mean (standard deviation) peak perioperative S was 114 (5) mmol/L, and hyperchloremia occurred in 824 (78.0%) of the cohort. In addition to administered volume of 0.9% saline, multivariate linear and logistic regression modeling consistently associated preoperative S (regression coefficient 0.5; 95% confidence interval [CI] 0.4-0.6 mmol/L; odds ratio 1.60; 95% CI 1.41-1.82 per 1 mmol/L increase) and cardiopulmonary bypass duration (regression coefficient 0.1; 95% CI 0.1-0.2 mmol/L; odds ratio 1.12; 95% CI 1.06-1.19 per 10 minutes) with both co-primary outcomes. Multivariate modeling only explained approximately 50% of variability in peak S.

CONCLUSIONS

The present study's data identified an association for both 0.9% saline administration and other nonfluid variables with peak perioperative S and hyperchloremia. Stand-alone strategies to limit administration of chloride-rich intravenous fluid may have limited ability to prevent hyperchloremia in this setting.

摘要

目的

除了 0.9%生理盐水外,对于可能导致心脏手术患者血清氯浓度(S)升高的因素知之甚少。在本研究中,作者试图描述静脉输液中的氯负荷与其他围手术期变量与围手术期 S 峰值之间的关系。

设计

对先前发表的一项对照临床试验数据的二次分析,其中患者被分配到富含氯或氯限制的围手术期液体策略(NCT02020538)。

地点

学术医疗中心。

参与者

本研究包括 1056 名术前 S 正常的成年心脏手术患者。

干预措施

测量和主要结果

选择围手术期 S 峰值和高氯血症(定义为 S 峰值>110mmol/L)作为共同主要终点。回归模型确定了与这些终点独立相关的因素。平均(标准差)围手术期 S 峰值为 114(5)mmol/L,队列中有 824 例(78.0%)发生高氯血症。除了 0.9%生理盐水的使用量外,多变量线性和逻辑回归模型一致地将术前 S(回归系数 0.5;95%置信区间[CI] 0.4-0.6mmol/L;比值比 1.60;95%CI 1.41-1.82 每增加 1mmol/L)和体外循环持续时间(回归系数 0.1;95%CI 0.1-0.2mmol/L;比值比 1.12;95%CI 1.06-1.19 每增加 10 分钟)与两个共同主要结局相关。多变量模型仅能解释 S 峰值变异性的约 50%。

结论

本研究的数据确定了 0.9%生理盐水的使用和其他非液体变量与围手术期 S 峰值和高氯血症的关系。单独限制富含氯的静脉输液的策略在这种情况下可能无法防止高氯血症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验